Scienjoy Competitors

So-Young International (NASDAQ:SY) and Scienjoy (NASDAQ:SJ) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, earnings, dividends and profitability.

Volatility & Risk

So-Young International has a beta of 0.35, suggesting that its share price is 65% less volatile than the S&P 500. Comparatively, Scienjoy has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current recommendations and price targets for So-Young International and Scienjoy, as reported by MarketBeat.com.

So-Young International presently has a consensus target price of $14.00, suggesting a potential upside of 61.66%. Scienjoy has a consensus target price of $56.00, suggesting a potential upside of 684.31%. Given Scienjoy's stronger consensus rating and higher probable upside, analysts plainly believe Scienjoy is more favorable than So-Young International.

Earnings & Valuation

This table compares So-Young International and Scienjoy's top-line revenue, earnings per share (EPS) and valuation.

So-Young International has higher revenue and earnings than Scienjoy.

Insider and Institutional Ownership

27.4% of So-Young International shares are owned by institutional investors. Comparatively, 0.1% of Scienjoy shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares So-Young International and Scienjoy's net margins, return on equity and return on assets.

Summary

So-Young International beats Scienjoy on 6 of the 11 factors compared between the two stocks.

Scienjoy (NASDAQ:SJ) and Tucows (NASDAQ:TCX) are both small-cap unclassified companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends and valuation.

Institutional and Insider Ownership

0.1% of Scienjoy shares are owned by institutional investors. Comparatively, 56.4% of Tucows shares are owned by institutional investors. 13.5% of Tucows shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Scienjoy and Tucows' net margins, return on equity and return on assets.

Risk & Volatility

Scienjoy has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500. Comparatively, Tucows has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500.

Valuation and Earnings

This table compares Scienjoy and Tucows' gross revenue, earnings per share (EPS) and valuation.

Tucows has higher revenue and earnings than Scienjoy.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Scienjoy and Tucows, as provided by MarketBeat.

Scienjoy currently has a consensus price target of $56.00, suggesting a potential upside of 684.31%. Tucows has a consensus price target of $70.00, suggesting a potential downside of 11.73%. Given Scienjoy's higher possible upside, research analysts plainly believe Scienjoy is more favorable than Tucows.

Summary

Tucows beats Scienjoy on 6 of the 10 factors compared between the two stocks.

Scienjoy (NASDAQ:SJ) and Sohu.com (NASDAQ:SOHU) are both small-cap unclassified companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Insider & Institutional Ownership

0.1% of Scienjoy shares are owned by institutional investors. Comparatively, 39.4% of Sohu.com shares are owned by institutional investors. 21.1% of Sohu.com shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Scienjoy and Sohu.com's net margins, return on equity and return on assets.

Risk & Volatility

Scienjoy has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, Sohu.com has a beta of 2.13, meaning that its stock price is 113% more volatile than the S&P 500.

Earnings & Valuation

This table compares Scienjoy and Sohu.com's gross revenue, earnings per share (EPS) and valuation.

Scienjoy has higher earnings, but lower revenue than Sohu.com.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Scienjoy and Sohu.com, as provided by MarketBeat.com.

Scienjoy currently has a consensus price target of $56.00, suggesting a potential upside of 684.31%. Sohu.com has a consensus price target of $26.6667, suggesting a potential upside of 48.98%. Given Scienjoy's stronger consensus rating and higher possible upside, equities analysts clearly believe Scienjoy is more favorable than Sohu.com.

Summary

Scienjoy beats Sohu.com on 7 of the 11 factors compared between the two stocks.

Scienjoy (NASDAQ:SJ) and Veritone (NASDAQ:VERI) are both small-cap unclassified companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Scienjoy and Veritone, as provided by MarketBeat.com.

Scienjoy currently has a consensus price target of $56.00, suggesting a potential upside of 684.31%. Veritone has a consensus price target of $30.1667, suggesting a potential upside of 65.12%. Given Scienjoy's stronger consensus rating and higher possible upside, equities analysts clearly believe Scienjoy is more favorable than Veritone.

Risk & Volatility

Scienjoy has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, Veritone has a beta of 3.55, meaning that its stock price is 255% more volatile than the S&P 500.

Profitability

This table compares Scienjoy and Veritone's net margins, return on equity and return on assets.

Insider & Institutional Ownership

0.1% of Scienjoy shares are owned by institutional investors. Comparatively, 28.1% of Veritone shares are owned by institutional investors. 25.6% of Veritone shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Scienjoy and Veritone's gross revenue, earnings per share (EPS) and valuation.

Scienjoy has higher earnings, but lower revenue than Veritone.

Summary

Scienjoy beats Veritone on 7 of the 12 factors compared between the two stocks.

Brightcove (NASDAQ:BCOV) and Scienjoy (NASDAQ:SJ) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations for Brightcove and Scienjoy, as provided by MarketBeat.

Brightcove presently has a consensus price target of $21.25, suggesting a potential upside of 58.23%. Scienjoy has a consensus price target of $56.00, suggesting a potential upside of 684.31%. Given Scienjoy's higher possible upside, analysts plainly believe Scienjoy is more favorable than Brightcove.

Profitability

This table compares Brightcove and Scienjoy's net margins, return on equity and return on assets.

Volatility & Risk

Brightcove has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Comparatively, Scienjoy has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500.

Earnings and Valuation

This table compares Brightcove and Scienjoy's gross revenue, earnings per share (EPS) and valuation.

Scienjoy has lower revenue, but higher earnings than Brightcove.

Insider and Institutional Ownership

84.5% of Brightcove shares are held by institutional investors. Comparatively, 0.1% of Scienjoy shares are held by institutional investors. 2.3% of Brightcove shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Scienjoy beats Brightcove on 6 of the 11 factors compared between the two stocks.

Scienjoy (NASDAQ:SJ) and IBEX (NASDAQ:IBEX) are both small-cap unclassified companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Earnings & Valuation

This table compares Scienjoy and IBEX's revenue, earnings per share and valuation.

IBEX has higher revenue and earnings than Scienjoy.

Profitability

This table compares Scienjoy and IBEX's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings for Scienjoy and IBEX, as reported by MarketBeat.com.

Scienjoy presently has a consensus target price of $56.00, suggesting a potential upside of 684.31%. IBEX has a consensus target price of $21.4286, suggesting a potential downside of 2.86%. Given Scienjoy's higher possible upside, equities analysts plainly believe Scienjoy is more favorable than IBEX.

Institutional and Insider Ownership

0.1% of Scienjoy shares are held by institutional investors. Comparatively, 23.2% of IBEX shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

IBEX beats Scienjoy on 5 of the 8 factors compared between the two stocks.